JM, H., X, C., MM, B., M, A., N, M., L, M., . . . JM, P. (2021). Real-world data on the infliximab biosimilar CT-P13 (Remsima (R)) in inflammatory bowel disease.
Chicago Style CitationJM, Huguet, Cortés X, Bosca-Watts MM, Aguas M, Maroto N, Martí L, Amorós C, and Paredes JM. Real-world Data On the Infliximab Biosimilar CT-P13 (Remsima (R)) in Inflammatory Bowel Disease. 2021.
MLA CitationJM, Huguet, et al. Real-world Data On the Infliximab Biosimilar CT-P13 (Remsima (R)) in Inflammatory Bowel Disease. 2021.
Warning: These citations may not always be 100% accurate.